Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation
Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute …
Writing Committee, TJ Gluckman, NM Bhave… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
COVID-19 and cardiovascular disease: from bench to bedside
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …
consequences on the cardiovascular health of millions of people who survive infection …
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
S Zhang, Y Liu, X Wang, L Yang, H Li, Y Wang… - Journal of hematology & …, 2020 - Springer
Background Critically ill patients diagnosed with COVID-19 may develop a pro-thrombotic
state that places them at a dramatically increased lethal risk. Although platelet activation is …
state that places them at a dramatically increased lethal risk. Although platelet activation is …
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
T Kotecha, DS Knight, Y Razvi, K Kumar… - European heart …, 2021 - academic.oup.com
Background Troponin elevation is common in hospitalized COVID-19 patients, but
underlying aetiologies are ill-defined. We used multi-parametric cardiovascular magnetic …
underlying aetiologies are ill-defined. We used multi-parametric cardiovascular magnetic …
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19
Several comorbidities have been shown to be associated with coronavirus disease 2019
(COVID-19) related severity and mortality. However, considerable variation in the …
(COVID-19) related severity and mortality. However, considerable variation in the …
COVID‐19 diagnosis and management: a comprehensive review
G Pascarella, A Strumia, C Piliego… - Journal of internal …, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus (SARS‐CoV)‐2, a novel coronavirus from
the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has …
the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has …
Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized …
2 METHODS This guidance statement is a collaborative effort of the Perioperative and
Critical Care Thrombosis and Haemostasis Subcommittee, along with members of the …
Critical Care Thrombosis and Haemostasis Subcommittee, along with members of the …